Ribrag V - Search Results

1

Efficacy and toxicity of 2 schedules of frontline rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone plus bortezomib in patients with B-cell lymphoma: a randomized phase 2 trial from the French Adult Lymphoma Study Group (GELA).

Ribrag V, Gisselbrecht C, Haioun C, Salles G, Golfier JB, Ertault M, Ferme C, Briere J, Brice P, Mounier N. Ribrag V, et al. Cancer. 2009 Oct 1;115(19):4540-6. doi: 10.1002/cncr.24518. Cancer. 2009. PMID: 19593797 Free article. Clinical Trial.

2

Acute myelogenous leukemia with T-cell features.

Ribrag V, Bayle C, Brault P, Bodis S, Magherini E, Hayat M. Ribrag V, et al. Bull Cancer. 1992;79(12):1165-71. Bull Cancer. 1992. PMID: 1304836

3

[Salvage chemotherapy of non-seminomatous germ cell tumors. Phase II trial of a combination of etoposide, ifosfamide and high-dose cisplatin].

Ribrag V, Droz JP, Bouleuc C, Theodore C, Ghosn M, Pico JL, Azab M, Ostronoff M, Hayat M. Ribrag V, et al. Presse Med. 1990 Jul 7-14;19(27):1263-6. Presse Med. 1990. PMID: 2143824 French.

4

[Chemotherapy in advanced transitional cell carcinoma of the urinary tract. Phase II trial of a combination of doxorubicin and cisplatin].

Ribrag V, Ghnassia M, Théodore C, Ghosn M, Piot G, Beurton D, Cukier J, Droz JP. Ribrag V, et al. J Urol (Paris). 1990;96(7):373-4. J Urol (Paris). 1990. PMID: 2290037 Clinical Trial. French.

5

[Salvage therapy of relapsing or refractory malignant lymphoma with non-myelotoxic combined chemotherapy. Results of combination of cisplatin, bleomycin, methyl-GAG and prednisolone (Cis-BMP)].

Brault P, Gilles E, Ribrag V, Bourhis JH, Munck JN, Pico JL, Hayat M. Brault P, et al. Among authors: ribrag v. Bull Cancer. 1995 Dec;82(12):1032-7. Bull Cancer. 1995. PMID: 8745669 French.

6

VIP (etoposide, ifosfamide and cisplatinum) as a salvage intensification program in relapsed or refractory Hodgkin's disease.

Ribrag V, Nasr F, Bouhris JH, Bosq J, Brault P, Girinsky T, Cosset JM, Munck JN, Corti C, Decaudin D, Pico JL, Hayat M, Carde P. Ribrag V, et al. Bone Marrow Transplant. 1998 May;21(10):969-74. doi: 10.1038/sj.bmt.1701202. Bone Marrow Transplant. 1998. PMID: 9632268 Clinical Trial.

7

Thrombotic microangiopathy: a new dose-limiting toxicity of high-dose sequential chemotherapy.

Vantelon JM, Munck JN, Bourhis JH, Pico JL, Fadel C, Ulusakarya A, Carde P, Fenaux P, Ribrag V. Vantelon JM, et al. Among authors: ribrag v. Bone Marrow Transplant. 2001 Mar;27(5):531-6. doi: 10.1038/sj.bmt.1702812. Bone Marrow Transplant. 2001. PMID: 11313688

8

Primary breast lymphoma: a report of 20 cases.

Ribrag V, Bibeau F, El Weshi A, Frayfer J, Fadel C, Cebotaru C, Laribi K, Fenaux P. Ribrag V, et al. Br J Haematol. 2001 Nov;115(2):253-6. doi: 10.1046/j.1365-2141.2001.03047.x. Br J Haematol. 2001. PMID: 11703318 Free article.

9

Hodgkin's disease primarily involving the oropharynx: case report and review of the literature.

Aloulou S, Farhat H, Bosq J, Vanel D, Ribrag V, Turhan AG, Girinsky T, Fermé C. Aloulou S, et al. Among authors: ribrag v. Hematol J. 2002;3(3):164-7. doi: 10.1038/sj.thj.6200166. Hematol J. 2002. PMID: 12111654 Review.

10

T-cell/histiocyte-rich large B-cell lymphomas and classical diffuse large B-cell lymphomas have similar outcome after chemotherapy: a matched-control analysis.

Bouabdallah R, Mounier N, Guettier C, Molina T, Ribrag V, Thieblemont C, Sonet A, Delmer A, Belhadj K, Gaulard P, Gisselbrecht C, Xerri L. Bouabdallah R, et al. Among authors: ribrag v. J Clin Oncol. 2003 Apr 1;21(7):1271-7. doi: 10.1200/JCO.2003.06.046. J Clin Oncol. 2003. PMID: 12663714

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

301 results

Search Page